43rd Annual J.P. Morgan Healthcare Conference 2025
Logotype for Envista Holdings Corporation

Envista (NVST) 43rd Annual J.P. Morgan Healthcare Conference 2025 summary

Event summary combining transcript, slides, and related documents.

Logotype for Envista Holdings Corporation

43rd Annual J.P. Morgan Healthcare Conference 2025 summary

10 Jan, 2026

Market overview and industry trends

  • Dental is a $40 billion global category, growing consistently at 3%-5% CAGR, supported by clinical, demographic, and economic factors.

  • The market experienced a post-COVID surge, followed by a softening due to normalization, higher interest rates, and lower consumer confidence.

  • Long-term growth is driven by aging populations, digitization, and expanding middle classes, with demand persistently exceeding supply.

  • Specialty categories like orthodontics and implants grow faster and have higher margins than general dental.

  • The market is currently described as soft but stable, with expectations for a return to normal growth as macro factors improve.

Company positioning and portfolio

  • Operates in four main product categories, serving the full continuum of dental care: diagnostics, treatment planning, therapeutics, and consumables.

  • Two-thirds of business is in specialty products (orthodontics and implants), with the rest in equipment and consumables.

  • Balanced portfolio by specialty, geography (50% US, 25% Europe, 25% developing markets), and go-to-market model (60% direct, 40% channel partners).

  • Holds top-three positions in key categories, with strong brands like Nobel Biocare (implants), Ormco (orthodontics), Kerr (consumables), and DEXIS (diagnostics).

  • Innovation legacy includes major dental advancements and a large patent portfolio.

Strategic priorities and investments

  • Reinstated guidance to improve business predictability and investor confidence.

  • Invested $25 million, mainly in commercial front-end and North American operations, to accelerate growth and fill open sales territories.

  • Focused on training clinicians, innovation, and operational productivity to leverage high-margin businesses.

  • Spark clear aligner business expected to become operating margin profitable in 2025, transitioning from cash consumer to generator.

  • Leadership team strengthened with experienced hires in key roles.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more